Guided Therapeutics GTHP
OTC GTHP
$0.20 +0.03 (+17.65%)
At close: Sep 29, 2026 · 4:00 PM EDT

Guided Therapeutics (GTHP) EV to EBITDA (2024)

Updated

Guided Therapeutics' EV to EBITDA came in at -1.34 for Q2 2024.

Analysis

Guided Therapeutics (GTHP) EV to EBITDA (2024) Analysis & Trends

Over the trailing twelve months to Jun 30, 2024, Guided Therapeutics reported EV to EBITDA of -10.13.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Guided Therapeutics 19.31 Mn 18.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.34
API Access

Guided Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GTHP&period=max&api_key=YOUR_API_KEY